Avalo Therapeutics Inc (AVTX): Sound like the evil Zionists wishing for...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	80
Posts	5615
Boards Moderated	0
Alias Born	11/18/2013

PennyPusher786

Re: everton44 post# 1544

Wednesday, 11/01/2023 10:17:54 AM

Wednesday, November 01, 2023 10:17:54 AM

Sound like the evil Zionists wishing for people's death. You're an evil sack of crap. You do realize we all die soon and face God.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent AVTX News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:02:12 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:00:44 AM
Avalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates • GlobeNewswire Inc. • 05/13/2026 11:00:00 AM
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/12/2026 10:09:39 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2026 08:20:27 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:18:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:16:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2026 08:15:10 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:54:16 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:32:13 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:30:36 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/06/2026 08:29:41 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/06/2026 03:00:55 PM
Avalo Therapeutics Announces Pricing of $375 Million Public Offering • GlobeNewswire Inc. • 05/06/2026 03:33:54 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/05/2026 08:28:31 PM
Avalo Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants • GlobeNewswire Inc. • 05/05/2026 08:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:01:30 PM
Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa • GlobeNewswire Inc. • 05/05/2026 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2026 08:37:50 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/29/2026 08:33:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 11:01:21 AM
Avalo Therapeutics Purchases Optional Milestone Buyout • GlobeNewswire Inc. • 04/28/2026 11:00:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/10/2026 08:02:49 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent AVTX News

More AVTX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent AVTX News

Go Ad-Free